xuehan Mao
64  results:
Search for persons X
?
1

Clinical Characteristics, Survival Outcomes and prognosis i..:

Jiahui, Liu ; huishou, Fan ; Xuehan, Mao...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e304 , 2019
 
?
2

Monitoring the cytogenetic architecture of minimal residual..:

yuting Yan ; xuehan Mao ; Fan huishou...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e187 , 2019
 
?
3

The prognostic impact of dynamic changing of cytogenetic ab..:

huishou, Fan ; Jiahui, Liu ; Xuehan, Mao...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e221-e222 , 2019
 
?
4

Development and validation of an individualized and weighte..:

Mao, Xuehan ; Yan, Wenqiang ; Mery, David...
American Journal of Hematology.  99 (2024)  4 - p. 523-533 , 2024
 
?
6

Clinical Benefit of Autologous Stem Cell Transplantation fo..:

Liu, Jiahui ; Yan, Wenqiang ; Fan, Huishou...
Cancer Research Communications.  3 (2023)  9 - p. 1770-1780 , 2023
 
?
7

P-173 Development and validation of an individualized and w..:

Yan, Wenqiang ; Mao, Xuehan ; David, Mery...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S130-S131 , 2023
 
?
 
?
12

The impact of response kinetics following initial therapy f..:

Yan, yuting ; Mao, xuehan ; Jiahui, Liu...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e222-e223 , 2019
 
?
13

IgH translocations with undefined partners are associated w..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e82-e83 , 2019
 
?
14

Multiple high-risk cytogenetic aberrations confer a progres..:

Mao, xuehan ; Xu, Yan ; Yan, yuting...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e83 , 2019
 
?
15

Real-world Outcomes of Chinese patients with high-risk Mult..:

Weiwei, Sui ; deng, shuhui ; An, gang...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e222 , 2019
 
1-15